Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1127289

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the affordability of medicines as a result of the redrafted WHO resolution entitled, Improving the transparency of markets for medicines, vaccines and other health-related technologies proposed by Italy on 29 April 2019.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255695
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:32:11 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden

855777

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	100,000 Genomes Project
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government has plans to commission an external evaluation of the 100,000 genomes project.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	131082
answer	answer is ministerial correction date of answer 08/03/2018 answer text <p>The project is regularly reviewed by Infrastructure and Projects Authority which provides independent assurance to the most complex and strategically significant projects across Government.</p><p> </p><p>A number of pilot sites were in operation prior to the start of the 100,000 Genomes Project. Following the evaluation of these pilot projects, processes were put in place for how the 100,000 Genomes Project is delivered at scale across the country.</p><p> </p><p>Learning from the 100,000 Genomes Project has been key to the development of a new National Genomic Medicine Service and National Genomic Test Directory by the National Health Service in England both of which will become operational in autumn 2018.</p><p> </p><p>A study ‘Understanding Experiences of Recruiting for and Participating in Genomics Research’ is being undertaken at the Departmental–funded Policy Innovation Research Unit. The study will include people's experience of taking part in the 100,000 Genomes Project and is due to report in 2018.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 08/03/2018 11:58:34 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4124 label Biography information for Chi Onwurah

1077183

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	22q11.2 Deletion Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect on the public purse of adding a test for 22q11 deletion syndrome to the newborn blood spot test.
tabling member constituency	Banff and Buchan
tabling member printed	David Duguid
uin	225599
answer	answer is ministerial correction date of answer 06/03/2019 answer text <p>No assessment has been made on adding a test for 22q11 deletion syndrome to the newborn blood spot test as the United Kingdom National Screening Committee’s (UK NSC) had not previously been asked to look at this condition.</p><p> </p><p>However, as part of the UK NSC`s annual call for topics 2018, a proposal was received to consider adding the condition of 22q11 deletion syndrome (also known as DiGeorge syndrome) to the new born blood spot programme.</p><p> </p><p>This is the first time the UK NSC has been asked to consider screening for 22q11. The UK NSC will be reviewing the proposal at its meeting at the end of the month and to agree next steps. Minutes of the meeting will then be published six weeks after and be made available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc" target="_blank">https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 225600 question first answered 06/03/2019 16:41:39 answering member 4067 label Biography information for Steve Brine
tabling member	4606 label Biography information for David Duguid

1077184

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	22q11.2 Deletion Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department’s policy is on adding a test for 22q11 deletion syndrome to the newborn blood spot test.
tabling member constituency	Banff and Buchan
tabling member printed	David Duguid
uin	225600
answer	answer is ministerial correction date of answer 06/03/2019 answer text <p>No assessment has been made on adding a test for 22q11 deletion syndrome to the newborn blood spot test as the United Kingdom National Screening Committee’s (UK NSC) had not previously been asked to look at this condition.</p><p> </p><p>However, as part of the UK NSC`s annual call for topics 2018, a proposal was received to consider adding the condition of 22q11 deletion syndrome (also known as DiGeorge syndrome) to the new born blood spot programme.</p><p> </p><p>This is the first time the UK NSC has been asked to consider screening for 22q11. The UK NSC will be reviewing the proposal at its meeting at the end of the month and to agree next steps. Minutes of the meeting will then be published six weeks after and be made available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc" target="_blank">https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 225599 question first answered 06/03/2019 16:41:39 answering member 4067 label Biography information for Steve Brine
tabling member	4606 label Biography information for David Duguid

922498

registered interest
date	12/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	22q11.2 Deletion Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to improve (a) awareness of and (b) diagnosis of 22Q11 deletion syndrome.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	152852
answer	answer is ministerial correction date of answer 15/06/2018 answer text <p>22q11.2 deletion syndrome is a disorder that involves many different areas of the body and the severity can vary among patients. 22q11.2 deletion syndrome is an integral part of the immunodeficiency section of the training curriculum for paediatric and adult immunologists. In addition, cardiac aspects of 22q deletion syndrome are specifically included in the curriculum for paediatric cardiology.</p><p> </p><p>There are 32 immunology centres accredited or working towards accreditation with the Quality in Primary Immunodeficiency Services programme including a number of paediatric immunology centres located across the United Kingdom, which provide services for patients affected by the disease. Such accreditation processes means that specialist expertise can be more readily available across the country and provide access to the services need in the diagnosis of this disease.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/06/2018 14:49:29 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

908944

registered interest
date	21/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5-aminolevulinic Acid
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his Department's press release of 14 May 2018 entitled Government announces £40 million for brain cancer research in honour of Tessa Jowell, what the planned timetable is for the roll-out of 5-AminoLevulinic Acid to all brain cancer centres in England.
tabling member constituency	Wigan
tabling member printed	Lisa Nandy
uin	146227
answer	answer is ministerial correction date of answer 23/05/2018 answer text <p>The fluorescent dye 5-AminoLevulinic Acid (5-ALA) is already in use in some brain cancer centres. NHS England has communicated its commitment to implementation in all relevant National Health Service trusts and is currently working with neurosurgical centres to ensure that 5-ALA is available for use in accordance with National Institute for Health and Care Excellence guidelines from July 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/05/2018 15:24:50 answering member 4067 label Biography information for Steve Brine
tabling member	4082 label Biography information for Lisa Nandy

1127892

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) health-and-safety research and (b) risk assessments his Department has (i) undertaken and (ii) commissioned on 5G technology.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	256910
answer	answer is ministerial correction date of answer 29/05/2019 answer text <p>Public Health England (PHE) has published a webpage about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:</p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p>This explains the health-related reviews and assessments have been performed, as well as the practical measures that are in place to protect public health.</p><p>PHE advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. The guidelines apply to exposures at frequencies up to 300 GHz, well above the maximum few tens of GHz frequencies anticipated for use by 5G systems.</p><p>Health and safety legislation requires companies deploying and operating communication networks to carry out suitable and sufficient risk assessments, as well as put in place measures to reduce the identified risks so far as reasonably practicable. In controlling risks arising from radio wave exposure, the Health and Safety Executive refer to compliance with the ICNIRP guidelines. Industry has committed to comply with the international guidelines and to provide certificates of compliance with planning applications for base stations.</p><p>PHE continues to monitor the health-related evidence applicable to radio waves, including in relation to base stations, and is committed to updating its advice as required.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256911 256912 question first answered 29/05/2019 10:34:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	252 label Biography information for Dr David Drew

1127894

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has (a) undertaken and (b) commissioned a regulatory safety testing on 5G radiofrequency radiation.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	256911
answer	answer is ministerial correction date of answer 29/05/2019 answer text <p>Public Health England (PHE) has published a webpage about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:</p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p>This explains the health-related reviews and assessments have been performed, as well as the practical measures that are in place to protect public health.</p><p>PHE advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. The guidelines apply to exposures at frequencies up to 300 GHz, well above the maximum few tens of GHz frequencies anticipated for use by 5G systems.</p><p>Health and safety legislation requires companies deploying and operating communication networks to carry out suitable and sufficient risk assessments, as well as put in place measures to reduce the identified risks so far as reasonably practicable. In controlling risks arising from radio wave exposure, the Health and Safety Executive refer to compliance with the ICNIRP guidelines. Industry has committed to comply with the international guidelines and to provide certificates of compliance with planning applications for base stations.</p><p>PHE continues to monitor the health-related evidence applicable to radio waves, including in relation to base stations, and is committed to updating its advice as required.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256910 256912 question first answered 29/05/2019 10:34:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	252 label Biography information for Dr David Drew

1127896

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to undertake (a) health-and-safety research and (b) a risk assessments before 5G is adopted in a localised test area.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	256912
answer	answer is ministerial correction date of answer 29/05/2019 answer text <p>Public Health England (PHE) has published a webpage about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:</p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p>This explains the health-related reviews and assessments have been performed, as well as the practical measures that are in place to protect public health.</p><p>PHE advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that radio wave exposures below the ICNIRP guideline levels cause adverse health effects. The guidelines apply to exposures at frequencies up to 300 GHz, well above the maximum few tens of GHz frequencies anticipated for use by 5G systems.</p><p>Health and safety legislation requires companies deploying and operating communication networks to carry out suitable and sufficient risk assessments, as well as put in place measures to reduce the identified risks so far as reasonably practicable. In controlling risks arising from radio wave exposure, the Health and Safety Executive refer to compliance with the ICNIRP guidelines. Industry has committed to comply with the international guidelines and to provide certificates of compliance with planning applications for base stations.</p><p>PHE continues to monitor the health-related evidence applicable to radio waves, including in relation to base stations, and is committed to updating its advice as required.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256910 256911 question first answered 29/05/2019 10:34:59 answering member 4455 label Biography information for Seema Kennedy
tabling member	252 label Biography information for Dr David Drew

1077327

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the public health risks of the full roll-out of 5G.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	225439
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>Electromagnetic fields (EMFs) and health evidence reviews have been prepared by scientific expert groups in the United Kingdom and around the world. The independent Advisory Group on Non-ionising Radiation (AGNIR) published their report in the UK in 2012 and the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) published their report in 2015. The World Health Organization is also currently preparing a review. The AGNIR report is available to view at following link:</p><p><a href="https://www.gov.uk/government/publications/radiofrequency-electromagnetic-fields-health-effects" target="_blank">https://www.gov.uk/government/publications/radiofrequency-electromagnetic-fields-health-effects</a></p><p>The SCENIHR report is available at the following link:</p><p><a href="https://ec.europa.eu/health/sites/health/files/scientific_committees/docs/citizens_emf_en.pdf" target="_blank">https://ec.europa.eu/health/sites/health/files/scientific_committees/docs/citizens_emf_en.pdf</a></p><p>Based on the accumulated evidence and reviews, Public Health England (PHE) advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and currently there is no strong evidence that EMF exposures below the ICNIRP guideline levels cause adverse health effects.</p><p>PHE has committed to keeping emerging evidence under review and to preparing another comprehensive review when sufficient new evidence has accumulated.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2019 16:25:49 answering member 4067 label Biography information for Steve Brine
tabling member	1506 label Biography information for Andrew Gwynne